Mr. Speaker, I thank the gentlewoman for yielding and for her exceptional leadership, along with Congressman Mike Castle's leadership on this exceptional and important issue. Mr. Speaker, I rise to express profound disappointment in the…
Mr. Speaker, I thank the gentlewoman for yielding and for her exceptional leadership, along with Congressman Mike Castle's leadership on this exceptional and important issue.
Mr. Speaker, I rise to express profound disappointment in the decision of the President to veto H.R. 810.
This legislation passed with strong bipartisan support in both Chambers of Congress. It enjoys the support of upwards of 70 percent of the American people and, most importantly, it offers hope and the promise of a cure to the millions of people who are living with the constant challenge and burdens of chronic disease and disability.
Mr. Speaker, when I was injured in an accidental shooting as a young police cadet almost 26 years ago, I was told that I would never walk again. The promise of embryonic stem cell research was at that time unheard of.
While I always held out hope that I would one day walk again, it was not until the tremendous potential and advances in the field of stem cell research that I truly understood how a cure might work. Today I am thrilled to be able to share this hope with millions of others.
We live in exciting times. Today, newly injured patients, many of them teenagers, as I was, are told about developing treatments and scientific progress. They face the world with many of the same challenges I faced in 1980, but they also face the world with the hope and real promise of a cure.
Under the current policy, however, that promise is limited. Embryonic stem cell research has been limited to the lines derived before August 9, 2001, the date of the President's policy announcement.
When the President announced his policy almost 5 years ago, even he acknowledged the tremendous potential of embryonic stem cell research. In fact, that policy allows the research to proceed but only in a very limited way. The resources that we had in 2001 have run out. This research cannot truly move forward without a change in policy. That is why I am disheartened by the President's decision today.
H.R. 810 was crafted according to the ethical guidelines outlined by the President, and it is why I will vote to override his veto today.
It authorizes research only on excess embryos originally created for in vitro fertilization but which are slated for destruction.
It requires informed, voluntary consent of the donor.
The only change to existing policy would be the lifting of the cutoff date of August 9. This is, in fact, not a debate about the ethics of stem cell research, or a debate about when life begins. It is a debate about a date.
H.R. 810 offers our nation's scientists the tools they need to proceed down this historic path. Stem cell research represents the most noble activity in which our government can engage: the protection, promotion, and, indeed, affirmation of the lives of our most vulnerable citizens.
With millions of American patients and their families in mind, I will proudly cast my vote today to override the President's veto. I urge all my colleagues to join me in support of the override.